Results 21 to 30 of about 7,752 (219)
Triptans in the Treatment of Migraine
, 2009 Migraine is a neurovascular disease, which pathogenesis is still unclear. It causes a severe headache and a substantial financial loss due to absenteeism, therefore, its effective treatment is particularly valuable.
Guldiken, Baburhan
core +3 more sources
Different characteristics of triptans [PDF]
, 2004 Despite the pharmacokinetic differences among triptans and the variety of ways of administration, the clinical differences in everyday use of these drugs do not allow a largely accepted decisional tree.
PINI, Luigi Alberto, BROVIA D.
core +1 more source
, 2023 Background: For many years triptans have been the cornerstone of acute migraine treatment. Nevertheless, treatment with triptans may not always be initiated due to contraindications (seen in approximately one fifth of patients) or inadequate response ...
Souza, Marcio Nattan Portes +3 more
core +1 more source
Current therapies in episodic migraine management [PDF]
Romanian Journal of Neurology, 2014 Migraine is a common neurological disease characterized by severe, recurrent episodes of throbbing, unilateral, headache. Non pharmacologic migraine treatment refers to the patient behavioural modification in order to avoid trigger.
Adina Roceanu, Ovidiu Bajenaru
doaj +1 more source
Of the available triptans, which should be chosen and how should they be used?
Headache Medicine, 2019 There is a plethora of articles dealing with the use of triptans to treat migraine, but so far no unanimity exists regarding the optimal form of using this group of drugs in a patient with recurrent attacks of migraine.
Marcelo Moraes Valença +7 more
doaj +1 more source
Romanian Journal of Neurology, 2022 Background. Migraine is a frequent neurological disorder affecting mostly women in the childbearing age. It is influenced by fluctuation of female hormones, especially estrogen levels. Objectives.
Andreea Elena Dumitru +4 more
doaj +1 more source
Why pharmacokinetic differences among oral triptans have little clinical importance: a comment. [PDF]
, 2010 Triptans, selective 5-HT1B/1D receptor agonists, are specific drugs for the acute treatment of migraine that have the same mechanism of action. Here, it is discussed why the differences among kinetic parameters of oral triptans have proved not to be very
Emilio Sternieri +7 more
core +1 more source
Triptans and spontaneous artery dissection
, 2021 Cases of spontaneous artery dissection have been reported to the French pharmacovigilance center network after triptan use. In this context, we will use the largest pharmacovigilance database worldwide, Vigibase, to collect and synthetize all cases of ...
Charles Khouri
core +1 more source
Use of triptans and associated factors: Prevelence Ratios (PR) and 95% Confience Intervals (95% CI).
, 2023 Use of triptans and associated factors: Prevelence Ratios (PR) and 95% Confience Intervals (95% CI).
Gian Camillo Manzoni (6257039) +14 more
core +1 more source
FORMULATION OF NANOPARTICLES OF ANTI-MIGRAINE DRUGS TRIPTANS BY COACERVATION METHOD [PDF]
, 2017 Objective: Triptans are effective medicines used to treat migraine and certain other headaches. This study has been conducted to prepared nanoparticles (NPs) of triptans by coacervation technique using a different drug to polymer ratios and evaluated ...
Csr, Lakshmi +3 more
core +2 more sources